California State Teachers Retirement System (CalSTRS)’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17M Sell
135,314
-1,630
-1% -$205K 0.02% 532
2025
Q1
$15.1M Buy
136,944
+395
+0.3% +$43.7K 0.02% 539
2024
Q4
$18.6M Buy
136,549
+2,389
+2% +$326K 0.02% 509
2024
Q3
$15.5M Sell
134,160
-3,645
-3% -$420K 0.02% 558
2024
Q2
$19M Sell
137,805
-6,600
-5% -$909K 0.02% 504
2024
Q1
$19.9M Sell
144,405
-326
-0.2% -$45K 0.03% 499
2023
Q4
$19.1M Sell
144,731
-920
-0.6% -$121K 0.03% 498
2023
Q3
$16.4M Sell
145,651
-7,038
-5% -$792K 0.03% 514
2023
Q2
$14.4M Sell
152,689
-4,742
-3% -$447K 0.02% 567
2023
Q1
$15.9M Sell
157,431
-573
-0.4% -$58K 0.02% 537
2022
Q4
$18.9M Buy
158,004
+2,467
+2% +$295K 0.03% 484
2022
Q3
$16.5M Sell
155,537
-1,589
-1% -$169K 0.03% 503
2022
Q2
$15.3M Buy
157,126
+953
+0.6% +$92.9K 0.02% 538
2022
Q1
$14.6M Sell
156,173
-9,515
-6% -$892K 0.02% 589
2021
Q4
$14.1M Buy
165,688
+1,674
+1% +$143K 0.02% 649
2021
Q3
$15.7M Sell
164,014
-3,780
-2% -$363K 0.02% 623
2021
Q2
$16.3M Sell
167,794
-7,356
-4% -$716K 0.02% 637
2021
Q1
$17M Buy
175,150
+2,236
+1% +$217K 0.02% 598
2020
Q4
$16.6M Buy
172,914
+4,432
+3% +$425K 0.02% 573
2020
Q3
$16.2M Buy
168,482
+3,935
+2% +$378K 0.03% 523
2020
Q2
$20.1M Buy
164,547
+7,803
+5% +$952K 0.04% 422
2020
Q1
$13.6M Sell
156,744
-2,350
-1% -$203K 0.03% 462
2019
Q4
$17.1M Buy
159,094
+13,560
+9% +$1.46M 0.03% 493
2019
Q3
$13.1M Buy
145,534
+1,734
+1% +$156K 0.03% 559
2019
Q2
$12.1M Buy
143,800
+1,349
+0.9% +$114K 0.02% 599
2019
Q1
$12.6M Buy
142,451
+2,127
+2% +$187K 0.03% 553
2018
Q4
$10M Buy
140,324
+3,164
+2% +$226K 0.02% 589
2018
Q3
$16.9M Sell
137,160
-48
-0% -$5.9K 0.03% 478
2018
Q2
$13.5M Buy
137,208
+1,507
+1% +$148K 0.03% 542
2018
Q1
$11.3M Sell
135,701
-2,872
-2% -$238K 0.02% 594
2017
Q4
$10.8M Sell
138,573
-2,137
-2% -$166K 0.02% 632
2017
Q3
$8.62M Sell
140,710
-14,992
-10% -$919K 0.02% 702
2017
Q2
$7.16M Sell
155,702
-14,849
-9% -$683K 0.02% 821
2017
Q1
$7.39M Sell
170,551
-8,000
-4% -$346K 0.01% 840
2016
Q4
$6.91M Sell
178,551
-4,800
-3% -$186K 0.01% 881
2016
Q3
$9.29M Buy
183,351
+1,500
+0.8% +$76K 0.02% 713
2016
Q2
$8.27M Buy
181,851
+363
+0.2% +$16.5K 0.02% 747
2016
Q1
$7.18M Buy
181,488
+23,225
+15% +$919K 0.02% 821
2015
Q4
$8.95M Buy
158,263
+2,458
+2% +$139K 0.02% 666
2015
Q3
$6.2M Sell
155,805
-200
-0.1% -$7.96K 0.02% 836
2015
Q2
$7.45M Buy
156,005
+1,309
+0.8% +$62.5K 0.02% 789
2015
Q1
$6.14M Buy
154,696
+13,300
+9% +$528K 0.01% 907
2014
Q4
$3.16M Buy
141,396
+1,199
+0.9% +$26.8K 0.01% 1303
2014
Q3
$2.2M Buy
140,197
+1,695
+1% +$26.6K 0.01% 1497
2014
Q2
$2.06M Buy
138,502
+1,400
+1% +$20.8K 0.01% 1587
2014
Q1
$2.21M Buy
137,102
+16,300
+13% +$262K 0.01% 1474
2013
Q4
$1.13M Buy
120,802
+700
+0.6% +$6.54K ﹤0.01% 1912
2013
Q3
$1.36M Buy
120,102
+3,816
+3% +$43.2K ﹤0.01% 1735
2013
Q2
$1.56M Buy
+116,286
New +$1.56M 0.01% 1553